Delivery Order SPE2DB22D2206-SPE2DB24FJS82

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $66K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET in 30-count units. The contract has a ceiling value of $19,560.72 and a period of performance through September 6, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen has been awarded numerous contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract has a total ceiling value of $66,891.35 and a period of performance through March 6, 2024. The contract is a firm fixed-price type and does not have any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30 per unit. The contract has a ceiling value of $42,085.67 and a performance period ending on May 12, 2025. This contract is not set-aside and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract has a ceiling value of $29,749.74 and runs through September 12, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the requested medication to support military treatment facilities and other federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract has a ceiling value of $17,647.87 and a period of performance through August 1, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, which serve as primary vehicles for delivering...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET in 30-count units. The order, valued at $13,707.59, is a firm fixed-price contract with an ultimate completion date of August 1, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $32,256.90 and a period of performance through April 7, 2025. The contract is a firm-fixed price delivery order and does not have a set-aside designation, indicating open...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, with a ceiling value of $80,078.96 and a performance period through May 24, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in units of 30s, with a ceiling value of $10,307.47 and a completion date of April 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of BIKTARVY 50-200-25 MG TABLET medical products, with a ceiling value of $36,066.84 and a completion date of February 13, 2025. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJS82
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET in 30-count units. The contract has a ceiling value of $66,398.69 and is set to expire on August 12, 2024.

AmerisourceBergen, through its Corporate Office division, is a key supplier of pharmaceutical products and medical supplies to various federal agencies and healthcare programs. This contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/8/24, 9:17 AM